Alvotech (ALVO) Enterprise Value (2020 - 2026)
Alvotech (ALVO) posted Enterprise Value of -$63.8 million for Q1 2026, up 62.97% on a QoQ basis from -$172.4 million in Q4 2025, and down 24.12% year-over-year from -$84.1 million in Q1 2025.
Alvotech (ALVO) Enterprise Value (2020 - 2026) Analysis & Trends
Alvotech's Enterprise Value history runs 7 years deep, the most recent figure standing at -$63.8 million for Q1 2026.
- Quarterly Enterprise Value fell 24.12% year-over-year to -$63.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$63.8 million (down 24.12% YoY) and the FY2025 annual result came in at -$172.4 million, down 235.15% from the prior year.
- Enterprise Value was -$63.8 million for Q1 2026 at Alvotech, up from -$172.4 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$10.9 million in Q2 2024 and bottomed at -$172.4 million in Q4 2025.
- A 5-year average of -$79.9 million and a median of -$64.3 million in 2024 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2023 — Enterprise Value jumped 83.2% — and 2025, when it plunged 1283.88%.
- Alvotech's Enterprise Value stood at -$66.4 million in 2022, then soared by 83.2% to -$11.2 million in 2023, then plunged by 360.95% to -$51.4 million in 2024, then tumbled by 235.15% to -$172.4 million in 2025, then soared by 62.97% to -$63.8 million in 2026.
- Business Quant data shows ALVO's Enterprise Value at -$63.8 million in Q1 2026, -$172.4 million in Q4 2025, and -$51.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | -1.86 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -3.74 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -1.94 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -4.05 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -2.15 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | -33.59 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -1.80 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -1.32 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -428.00 Mn |
| 10 | Alvotech | 935.87 Mn | 935.87 Mn | 5.09 Mn | -63.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -63.83 Mn |
| Dec 31, 2025 | -172.36 Mn |
| Sep 30, 2025 | -51.43 Mn |
| Jun 30, 2025 | -151.45 Mn |
| Mar 31, 2025 | -51.43 Mn |
| Dec 31, 2024 | -51.43 Mn |
| Sep 30, 2024 | -118.27 Mn |
| Jun 30, 2024 | -10.94 Mn |
| Mar 31, 2024 | -64.81 Mn |
| Dec 31, 2023 | -11.16 Mn |
| Jun 30, 2023 | -60.47 Mn |
| Mar 31, 2023 | -115.84 Mn |
| Dec 31, 2022 | -66.43 Mn |
| Jun 30, 2022 | -128.44 Mn |
| Dec 31, 2021 | -17.56 Mn |
| Dec 31, 2020 | -31.69 Mn |